<funding-group>
Funding Group (資金提供グループ)
記事内で報告されている研究の資金調達 (例えば助成、契約、出資者) 及び記事自体へのオープンア
クセス手数料に関する情報のコンテナ要素。
備考
オープンアクセス情報には、オープンアクセス資金のどのモデルを資金提供者が選択したか、オープンアクセス料金を支払ったのは誰か、またはどのような料金が適用されたかなどが含まれます。
コンテンツ・モデル
<!ELEMENT funding-group
%funding-group-model; >拡張コンテンツ・モデル
(award-group*, funding-statement*, open-access*)
記述方法
以下の順:
- <award-group> (研究助成グループ)、ゼロまたは 1 個以上
- <funding-statement> (資金提供ステートメント)、ゼロまたは 1 個以上
- <open-access> (オープン・アクセス)、ゼロまたは 1 個以上
この要素は以下の要素内に含むことができます:
用例 1
資金提供情報メタデータと、同じ情報を記載している記事本文中の謝辞要素:
<article dtd-version="1.1"> <front> <journal-meta> <journal-id>xxxx</journal-id> <issn>xxxxx</issn> </journal-meta> <article-meta>... <abstract>...</abstract> <kwd-group kwd-group-type="author">...</kwd-group> <funding-group> <award-group id="nih-509"> <funding-source country="US">NIH</funding-source> <award-id>NIH GM61374</award-id> <principal-award-recipient>Stanford</principal-award-recipient> </award-group> </funding-group> <funding-group> <award-group id="nsf-510"> <funding-source country="US">NSF</funding-source> <award-id>NSF DBI-0317510</award-id> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> <award-group id="arda-511" award-type="contract"> <funding-source country="US">ARDA ACQUAINT</funding-source> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> <award-group id="geneentech-512" award-type="gift"> <funding-source country="US">Genentech Corp.</funding-source> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> </funding-group> </article-meta> </front> <body>...</body> <back> <ack> <p>... Part of the research at Stanford was supported by NIH GM61374. The Berkeley portion of this research was supported by NSF DBI-0317510, an ARDA AQUAINT contract, and a gift from Genentech Corp.</p> </ack> ...</back> </article>
用例 2
資金提供情報メタデータがこの <funding-statement> 要素内でのみ記述され、記事本文には記載がない例:
...
<article-meta>...
<kwd-group kwd-group-type="author">...</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source id="GS1"
xlink:href="http://www.phrmafoundation.org/">Pharmaceutical
Research and Manufacturers of America Foundation</funding-source>
</award-group>
<award-group id="award2" award-type="grant">
<funding-source id="GS2"
xlink:href="http://www.energy.gov">United States Department
of Energy Office of Science (BER)</funding-source>
<award-id rid="GS2">DE-FG02-04ER63803</award-id>
</award-group>
<award-group id="award3">
<funding-source id="GS3" xlink:href="http://www.nih.gov">National
Institutes of Health</funding-source>
</award-group>
<award-group id="award4">
<funding-source id="GS4" xlink:href="http://www.nsf.gov">National
Science Foundation</funding-source>
<award-id rid="GS4" >FIBR Award EF-0425719</award-id>
</award-group>
<award-group id="award5">
<funding-source id="GS5"
xlink:href="http://www.nhlbi.nih.gov/meetings/proteomics.htm">National
Heart, Lung, and Blood Proteomics Initiative</funding-source>
<award-id rid="GS5">HHSN268200248178C</award-id>
</award-group>
<award-group id="award6">
<funding-source id="GS6">Whitaker Foundation</funding-source>
</award-group>
<award-group id="award7">
<funding-source id="GS7">Cellicon Biotechnologies, Inc.</funding-source>
</award-group>
<funding-statement><bold>Funding.</bold> <uri
xlink:href="http://www.phrmafoundation.org/">Pharmaceutical Research
and Manufacturers of America Foundation</uri>, the
<uri xlink:href="http://www.energy.gov">United States
Department of Energy Office of Science (BER)</uri> grant
number DE-FG02-04ER63803, the
<uri xlink:href="http://www.nih.gov">National Institutes of
Health</uri>, <uri
xlink:href="http://www.nsf.gov">National Science Foundation</uri>
FIBR Award EF-0425719,
the <uri
xlink:href="http://www.nhlbi.nih.gov/meetings/proteomics.htm">National
Heart, Lung, and Blood Proteomics Initiative</uri> (
HHSN268200248178C), the
Whitaker Foundation, and Cellicon
Biotechnologies, Inc.</funding-statement>
</funding-group>
</article-meta>
...